Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Tenet Healthcare's 3-Year RORE % for the quarter that ended in Mar. 2026 was -7.82%.
The industry rank for Tenet Healthcare's 3-Year RORE % or its related term are showing as below:
MEX:THC's 3-Year RORE % is ranked worse than 60.07% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 0.195
vs MEX:THC: -7.82
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Tenet Healthcare 3-Year RORE % Related Terms
Tenet Healthcare 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Tenet Healthcare's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:THC vs DVA, EHC, ENSG: 3-Year RORE % Comparison
For the Medical Care Facilities subindustry, Tenet Healthcare's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tenet Healthcare 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tenet Healthcare's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Tenet Healthcare's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
Tenet Healthcare (MEX:THC) has a 3-Year RORE % of -7.82 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Tenet Healthcare and its competitors. According to the industry distribution chart, Tenet Healthcare ranks #364 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 60.1%.
Is Tenet Healthcare's 3-Year RORE % too high?
Tenet Healthcare's current 3-Year RORE % is -7.82. Based on the distribution chart, Tenet Healthcare ranks #364 out of 606 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Tenet Healthcare has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Tenet Healthcare's 3-Year RORE % compare to DVA and EHC?
According to the Healthcare Providers & Services industry distribution chart, Tenet Healthcare ranks #364 out of 606 companies for 3-Year RORE %. This places Tenet Healthcare in the lower half of its industry. The industry median 3-Year RORE % is 0.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.20, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Tenet Healthcare and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tenet Healthcare's current 3-Year RORE % is -7.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenet Healthcare stock overvalued right now?
Tenet Healthcare (MEX:THC) has a current 3-Year RORE % of -7.82. The stock's GF Value™ is MXN2,867.15, compared to a current price of MXN3,547.50 — trading 23.7% above its estimated fair value. The current 3-Year RORE % is -7.82. Tenet Healthcare's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Tenet Healthcare (MEX:THC), the current 3-Year RORE % is -7.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tenet Healthcare (MEX:THC) Overvalued in 2026?
Based on GuruFocus' analysis, Tenet Healthcare stock appears to be overvalued.
The current stock price of MXN3,547.50 is trading 23.7% above its estimated GF Value™ of MXN2,867.15.
Key valuation signals for MEX:THC:
3-Year RORE %: -7.82
GF Value™: MXN2,867.15 vs. price of MXN3,547.50 (23.7% above fair value)
No single metric tells the full story. See the MEX:THC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
77GF Score
Get the complete analysis for MEX:THC
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:THC has been successfully added to your 
